secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001493152-24-032700
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics appoints Gregory S. Curhan as CFO, replaces departing interim CFO Andrea Park
--------------------------------------------------------------------------------

- Gregory S. Curhan appointed CFO effective Aug 16, 2024; compensated at $650/hour plus 250k-share option vesting over 48 months.
- Andrea Park, interim CFO and CAO, departs effective Aug 15, 2024.
- Curhan is partner at FLG Partners and also CFO of Curevo Vaccines.
- Option accelerates on change of control or $60M equity transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224032700/0001493152-24-032700-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224032700/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-032700

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer